IL21 and infection: Together with those of Figure 5, these data indicate that in IL-21-treated RMs a better preservation of intestinal Th17 cells in early infection is associated with reduced levels of intestinal T cell proliferation, microbial translocation and systemic inflammation in the chronic stage of infection.